Authors: Chuntharapai, A Lai, J Huang, XJ Gibbs, V Kim, KJ Presta, LG Stewart, TA

Citation: A. Chuntharapai et al., Characterization and humanization of a monoclonal antibody that neutralizes human leukocyte interferon: A candidate therapeutic for IDDM and SLE, CYTOKINE, 15(5), 2001, pp. 250-260

Authors: Idusogie, EE Wong, PY Presta, LG Gazzano-Santoro, H Totpal, K Ultsch, M Mulkerrin, MG

Citation: Ee. Idusogie et al., Engineered antibodies with increased activity to recruit complement, J IMMUNOL, 166(4), 2001, pp. 2571-2575

Authors: Shields, RL Namenuk, AK Hong, K Meng, YG Rae, J Briggs, J Xie, D Lai, J Stadlen, A Li, B Fox, JA Presta, LG

Citation: Rl. Shields et al., High resolution mapping of the binding site on human IgG1 for Fc gamma RI,Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R, J BIOL CHEM, 276(9), 2001, pp. 6591-6604

Authors: Clynes, RA Towers, TL Presta, LG Ravetch, JV

Citation: Ra. Clynes et al., Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets, NAT MED, 6(4), 2000, pp. 443-446

Authors: Idusogie, EE Presta, LG Gazzano-Santoro, H Totpal, K Wong, PY Ultsch, M Meng, YG Mulkerrin, MG

Citation: Ee. Idusogie et al., Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc, J IMMUNOL, 164(8), 2000, pp. 4178-4184

Authors: O'Connell, L Hongo, JA Presta, LG Tsoulfas, P

Citation: L. O'Connell et al., TrkA amino acids controlling specificity for nerve growth factor, J BIOL CHEM, 275(11), 2000, pp. 7870-7877